Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial"

Affiliations

¹ Duke Clinical Research Institute, Durham, NC.
² East Carolina University, Greenville, NC.
³ North Carolina State University, Raleigh, NC.
⁴ Cardiopulmonary Research Science and Technology Institute, Dallas, TX.
⁵ Missouri Baptist Medical Center, St Louis, MO.
⁶ Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands.
⁷ PERFUSE Angiographic Laboratory, Boston, MA.
⁸ Department of Medicine, Stanford University, Stanford, CA.

Comment

Ralf E Harskamp et al. Circulation. 2016.

. 2016 May 24;133(21):e665.

doi: 10.1161/CIRCULATIONAHA.116.022510.

¹ Duke Clinical Research Institute, Durham, NC.
² East Carolina University, Greenville, NC.
³ North Carolina State University, Raleigh, NC.
⁴ Cardiopulmonary Research Science and Technology Institute, Dallas, TX.
⁵ Missouri Baptist Medical Center, St Louis, MO.
⁶ Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands.
⁷ PERFUSE Angiographic Laboratory, Boston, MA.
⁸ Department of Medicine, Stanford University, Stanford, CA.

No abstract available

Comment on

Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial.
Harskamp RE, Alexander JH, Ferguson TB Jr, Hager R, Mack MJ, Englum B, Wojdyla D, Schulte PJ, Kouchoukos NT, de Winter RJ, Gibson CM, Peterson ED, Harrington RA, Smith PK, Lopes RD. Harskamp RE, et al. Circulation. 2016 Jan 12;133(2):131-8. doi: 10.1161/CIRCULATIONAHA.115.015549. Epub 2015 Dec 8. Circulation. 2016. PMID: 26647082 Free PMC article.
Letter by Picard and Ly Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".
Picard F, Ly HQ. Picard F, et al. Circulation. 2016 May 24;133(21):e663. doi: 10.1161/CIRCULATIONAHA.116.021286. Circulation. 2016. PMID: 27217437 No abstract available.
Letter by Poullis and Pullan Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".
Poullis M, Pullan M. Poullis M, et al. Circulation. 2016 May 24;133(21):e664. doi: 10.1161/CIRCULATIONAHA.116.021513. Circulation. 2016. PMID: 27217438 No abstract available.